Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo
The DOI matches its Crossref record.
Abstract
Acute inhibition of monoamine oxidase B (MAO‐B) in the rat does not affect striatal dopamine (DA) metabolism, but chronic MAO‐B inhibition with deprenyl has been reported to increase the release of striatal DA, as shown using in vitro techniques. To see whether chronic MAO‐B inhibition also causes an increase in DA release in vivo, rats were treated for 21 days with either deprenyl (0.25 mg/kg), TVP‐1012 [R(+)‐N‐propargyl‐1‐aminoindan mesylate; 0.05 mg/kg), an irreversible inhibitor of MAO‐B that is not metabolized to amphetamines, clorgyline (0.2 mg/kg), or saline (all doses once daily by subcutaneous injection). Concentric 4‐mm‐long microdialysis probes were implanted in the left striatum under pentobarbital/chloral hydrate anesthesia on day 21, and microdialysate DA, 3,4‐dihydroxyacetic acid (DOPAC), and 4‐hydroxy‐3‐methoxyphenyl acetic acid (HVA) were determined in the conscious animals on day 22. Baseline levels of DA were as follows: control, 0.34 ± 0.04 (n = 13); deprenyl, 0.88 ± 0.10 (n = 8, p < 0.01); TVP‐1012, 0.94 ± 0.20 (n = 7, p < 0.01); clorgyline, 0.90 ± 0.12 (n = 7, p < 0.01) pmol/20 min. Levels of DOPAC and HVA were reduced only in the clorgyline‐treated group. The incremental release of DA induced by depolarizing concentration of K+ (100 m M bolus of KCl in perfusate) was significantly greater in clorgyline‐ and deprenyl‐treated rats and elevated (nonsignificantly) in TVP‐1012‐treated rats. Chronic treatment with the MAO‐B inhibitors reduced striatal MAO‐B activity by 90%, with 15% (TVP‐1012) or 40% (deprenyl) inhibition of MAO‐A. Clorgyline inhibited MAO‐A by 95%, with 30% inhibition of MAO‐B. A single dose of deprenyl (0.25 mg/kg, 24 h before microdialysis) had no significant effect on striatal efflux of DA. The results show that DA metabolism was reduced only by clorgyline, whereas neuronal release of DA was enhanced by both MAO‐A and MAO‐B inhibitors on chronic administration. The enhanced DA release by chronic MAO‐B inhibition does not appear to be dependent on production of amphetamine‐like metabolites of the inhibitor. Possible mechanisms for the release‐enhancing effect of the MAO‐B inhibitors include elevation in levels of endogenous β‐phenylethylamine, or an inhibition of DA reuptake, which develops only on chronic administration, because both deprenyl and TVP‐1012 have only very weak effects on amine uptake in acute experiments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101
“However, we postulate that drugs that increase the amount of DA that is being released as a function of DA cell firing (such as MAO B inhibitors, which enhance DA release in response to DA stimulation presumably by their inhibition of DA degradation”
BackgroundInhibitors of MAO-A and MAO-B in Psychiatry and Neurology
Finberg, J. P. M., & Rabey, J. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00340 · Cited by 432
Self-citationFinberg, J. P. M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.010 · Cited by 257
Self-citationGal, S., Zheng, H., Fridkin, M., & Youdim, M. B. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03341.x · Cited by 185
“(2005) 95, 79–88 studies and its increased turnover as reflected in DOPAC plus HVA/DA, suggest increased DA release, as has been reported previously with other MAO inhibitors (Lamensdorf et al. 1996).”
BackgroundResultSelf-citationGal, S., Fridkin, M., Amit, T., Zheng, H., & Youdim, M. B. H. (2006) · Parkinson’s Disease and Related Disorders · doi:10.1007/978-3-211-45295-0_68 · Cited by 58
Self-citation
Metadata
- Authors
- Lamensdorf, I., Youdim, M. B. H., & Finberg, J. P. M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1996-10
- Volume
- 67
- Issue
- 4
- Pages
- 1532-1539
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2104795285
- Cited by
- 131
- References
- 0
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo. https://app.cochat.ai/papers/10.1046/j.1471-4159.1996.67041532.x
- The paper
- Lamensdorf, I., Youdim, M. B. H., & Finberg, J. P. M. (1996). Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.1996.67041532.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.